Skip to main content

Illumina Will Help Sanger Institute Create Hap Map

NEW YORK, July 25-Illumina said yesterday that it would provide SNP genotyping services for Britain's Wellcome Trust Sanger Institute to build a haplotype map of a substantial section of the human genome.


Illumina will develop assays for the Sanger SNP collection and use its own technology to genotype those SNPs.


Financial details of the arrangement were not revealed.


The arrangement follows a pilot genotyping study that Illumina conducted for the Sanger Institute in 2001.


Illumina is a San Diego-based public company.


For further details, see the press release.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.